SalaryGuide
AboutPricingFor Employers

Marketing jobs

25 marketing jobs

Kenvue logo
3 months ago

Director, HCP Marketing - Listerine

Kenvue

Summit, NJ (Hybrid)Full time$191K/yr – $269K/yr
Kenvue logo
3 months ago

Marketing Manager, Listerine Global

Kenvue

Summit, NJ (Hybrid)Full time$124K/yr – $175K/yr
Kenvue logo
3 months ago

Global Brand Manager, Future Skin Healing

Kenvue

Summit, NJ (Hybrid)Full time$124K/yr – $175K/yr
Kenvue logo
4 months ago

Director, HCP Marketing - Listerine

Kenvue

Summit, NJ (Hybrid)$191K/yr – $269K/yr
Kenvue logo
4 months ago

Director, Social Commerce

Kenvue

Summit, NJ (Hybrid)Full time$191K/yr – $269K/yr
Previous
12
Next

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

25 jobs
Kenvue logo

Director, HCP Marketing - Listerine

Kenvue

Summit, NJ (Hybrid)

$191K/yr - $269K/yrIn-houseFull-timeDirector/executive12+ years exp.
3 months ago
Kenvue logo

Marketing Manager, Listerine Global

Kenvue

Summit, NJ (Hybrid)

$124K/yr - $175K/yrIn-houseFull-timeSenior level5+ years exp.
3 months ago
Kenvue logo

Global Brand Manager, Future Skin Healing

Kenvue

Summit, NJ (Hybrid)

$124K/yr - $175K/yrIn-houseFull-timeSenior level5+ years exp.
3 months ago
Kenvue logo

Director, HCP Marketing - Listerine

Kenvue

Summit, NJ (Hybrid)

$191K/yr - $269K/yrIn-houseDirector/executive12+ years exp.
4 months ago
Kenvue logo

Director, Social Commerce

Kenvue

Summit, NJ (Hybrid)

$191K/yr - $269K/yrIn-houseFull-timeDirector/executive8+ years exp.
4 months ago
Previous12
Kenvue logo
Kenvue

Director, HCP Marketing - Listerine

Summit, NJ (Hybrid)

$191K/yr – $269K/yrDirector/Executive12+ years expFull time

Posted 3 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own HCP marketing leadership for Dental Professionals and Listerine, guiding global strategy, omnichannel toolkits, and KOL partnerships.

  • Develop HCP strategy by target audience and brand impact on penetration and NTS
  • Develop omnichannel communications toolkit of assets to be deployed by markets
  • Define benefits HCPs can expect from our product or service, execution & deployment

Job Description

Own HCP marketing leadership for Dental Professionals and Listerine, guiding global strategy, omnichannel toolkits, and KOL partnerships.

  • Develop HCP strategy by target audience and brand impact on penetration and NTS
  • Develop omnichannel communications toolkit of assets to be deployed by markets
  • Define benefits HCPs can expect from our product or service, execution & deployment
Kenvue logo

Kenvue

3.6 Glassdoor

Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage and propelled forward by science, our iconic brands — including Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®, Neutrogena®, Tylenol® and Zyrtec® — are recommended by health care professionals and can be trusted by consumers who use our products to improve their daily lives. Our team members share a digital-first mindset, with an approach to innovation grounded in deep human insights and work every day to earn a place for our products in consumers’ hearts and homes. At Kenvue, we believe everyday care can not only make people well; it can make them whole.Beware of recruitment scams: https://www.kenvue.com/media/recruitment-scams-alert

Founded in 2023
Summit, New Jersey, USA
19K employees (1,980 in marketing)
www.kenvue.com
64% recommend to a friend
61% CEO approval

Traffic Signals

Monthly Visitors
221.6K
Traffic Source Mix
Search
46.1%
Direct
39.6%
Referral
10.4%
Social
2.6%
Paid
1%

Headcount Trend

Current headcount: ~19K

Marketing Team

Marketing Team Size
1,725 (9% of company)
Median Career Experience
12 years
Median Tenure
3.1 years
Marketing Roles Posted (Last 30 Days)
10

People

HR / Recruitment

Gina Caccimelio
Gina Caccimelio
Talent Access Lead, NA Commercial and Global Brand Marketing
At the company for 1 year 9 months

Marketing Leadership

Marguerite Longo
Marguerite Longo
Vice President, Marketing - Global Pain (Tylenol, Motrin+)
At the company for 3 years 3 months
Kristen (Smith) Wallace
Kristen (Smith) Wallace
Vice President, External Communications & Corporate Brand
At the company for 3 years 3 months
Nicole Klitchko
Nicole Klitchko
Head of US Brand Communications
At the company for 3 years 6 months
Kevin Shapiro
Kevin Shapiro
Head of US Neutrogena Brand Growth Sun & Skincare
At the company for 1 year 1 month

Funding

Total Funding
$3.6B
Last Raise
$3.6B
Post IPO Equity, 11 months ago

Funding History

  • Apr 2025
    Post IPO Equity
  • Oct 2024
    Post IPO Equity
  • May 2024
    Post IPO Secondary • $3.6B

Recent News

Donald Trump’s Tylenol Warning Makes Kenvue Stock (KVUE) an Opportunity in Disguise
Oct 8, 2025 • TipRanks
Near 52-Week Low, Should You Buy Kenvue Stock?
Oct 8, 2025 • The Motley Fool
Consumer health giant Kenvue begins global agency review
Oct 1, 2025 • Campaign US
Should You Buy Kenvue Stock After Its 30% Plunge?
Oct 1, 2025 • The Motley Fool
'This team is guided by science': Kenvue chief hits back at Trump and RFK Jr.'s Tylenol autism claims in memo to 20,000 employees
Oct 1, 2025 • Fortune
Tylenol marketer Kenvue launches global creative and media review
Sep 30, 2025 • Ad Age
Investing.com’s stocks of the week
Sep 27, 2025 • Investing.com
Jim Cramer Discusses Kenvue Inc. (KVUE) & Legal Issues
Sep 26, 2025 • Yahoo Finance
Health agencies reaffirm Tylenol safe in pregnancy after Trump remarks
Sep 26, 2025 • Taiwan Sun
Chair of a House committee on China demands urgent White House briefing on TikTok deal
Sep 26, 2025 • Cheddar
J&J: Still a Defensive Giant, or Too Dependent on Pharma?
Sep 26, 2025 • GuruFocus
Dr. Oz says "of course" pregnant women should take Tylenol if a doctor says so
Sep 26, 2025 • CBS News
Trump says not to give young children Tylenol
Sep 26, 2025 • MarketScreener
Analyst recommendations: Carmax, American Airlines, Applovin, Pure Storage…
Sep 26, 2025 • MarketScreener
Rothschild upgrades Kenvue after Tylenol scare wipes $10 billion in market value
Sep 26, 2025 • Investing.com
Moderately bullish activity in Kenvue Inc with shares up 0.4%
Sep 26, 2025 • thefly.com
Trump again warns against Tylenol use during pregnancy and childhood
Sep 26, 2025 • Investing.com
Tylenol Maker Kenvue Faces Mounting Crisis After Trump Blast
Sep 24, 2025 • Yahoo Finance
As Trump Takes Aim at Tylenol, Should You Buy, Sell, or Hold Parent Company Kenvue Stock’s Here?
Sep 24, 2025 • Barchart.com
Tylenol maker prepares for glut of lawsuits after Trump’s baseless warnings
Sep 24, 2025 • The Independent
Tylenol Maker Kenvue Shares Rebound After Trump Links Drug To Autism
Sep 23, 2025 • Forbes
"Facts Remain Unchanged": Tylenol Maker After Trump Links It With Autism
Sep 23, 2025 • NDTV
Kenvue Stock Rebounds After Trump Links Tylenol to Autism. Here’s Why.
Sep 23, 2025 • Barron's
Kenvue Braces for Wave of New Lawsuits Over Tylenol’s Potential Link to Autism
Sep 23, 2025 • The Wall Street Journal
Kenvue (KVUE) Falls to New All-Time Low as Trump Hits Tylenol
Sep 23, 2025 • Yahoo Finance
Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism
Sep 23, 2025 • Investopedia
Kenvue stock rallies off record low after Trump press conference on alleged Tylenol-autism link
Sep 23, 2025 • MarketWatch
Tylenol maker's stock bounces back after Trump baselessly links painkiller to autism
Sep 23, 2025 • qz.com
Kenvue issues official company statement on Tylenol
Sep 23, 2025 • Mass Market Retailers
Tylenol-Maker Kenvue’s Stock Reacts to President Trump’s Autism Announcement
Sep 23, 2025 • Pharmaceutical Executive
Tylenol: Kenvue's Sobering Reality (NYSE:KVUE)
Sep 23, 2025 • Seeking Alpha
Tylenol-maker Kenvue shares bounce back, Trump claims face pushback
Sep 23, 2025 • Reuters
Tylenol maker Kenvue blasts Trump administration's autism claim
Sep 22, 2025 • Axios
Trump to Announce Link Between Tylenol and Autism. Kenvue Stock Hits Record Low.
Sep 22, 2025 • Barron's
Tylenol-maker Kenvue's stock is down 25% in 6 months as it battles repeated autism link claims
Sep 22, 2025 • Fortune
Tylenol maker Kenvue plunges on reports that the White House planned to link the drug to autism
Sep 22, 2025 • Business Insider
Kenvue stock falls after report of Trump admin linking Tylenol to autism
Sep 22, 2025 • Investing.com
Tylenol maker says it ‘strongly disagrees’ with Trump’s claims about acetaminophen
Sep 22, 2025 • PBS
What is Kenvue? The Tylenol maker facing RFK Jr. scrutiny over autism claims
Sep 22, 2025 • USA Today
Kenvue Stock Hits All-Time Low, Turns Higher After-Hours
Sep 22, 2025 • The Wall Street Journal
Kenvue Stock Sinks Ahead of Trump Announcement Tying Autism to Tylenol Use During Pregnancy
Sep 22, 2025 • Investopedia
President Trump ignited a public relations nightmare for the company behind Tylenol. In extraordinary remarks giving direct medical advice, Trump claimed unproven links between the pain reliever and autism.
Sep 22, 2025 • facebook.com
Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis
Sep 22, 2025 • The New York Times
Kenvue says Tylenol is safe, but stock hits record low as Trump makes unproven link to autism
Sep 22, 2025 • MarketWatch
Study highlights gaps in cough management, calls for scientific approach to its categorisation
Sep 16, 2025 • The Hindu
Cough in India often treated with unnecessary antibiotics: Study
Sep 16, 2025 • IndiaTimes
3 Dividend Stocks to Hold Through Market Volatility This Fall
Sep 16, 2025 • MarketBeat
Kenvue price target lowered by $2 at Citi, here's why
Sep 16, 2025 • thefly.com
Kenvue CEO Sough to Prevent RFK Jr. From Citing Tylenol as Potential Autism Cause
Sep 15, 2025 • MarketScreener
Kenvue Localizes Listerine Strategy to Stay Ahead in China's Oral Care Race
Sep 15, 2025 • yicaiglobal.com
Kenvue mulls defense if Tylenol linked to autism (KVUE:NYSE)
Sep 12, 2025 • Seeking Alpha
Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports
Sep 12, 2025 • Reuters
Kenvue CEO Met With Robert F. Kennedy Jr. To Argue There's No Clear Link Between Tylenol And Autism - WSJ
Sep 12, 2025 • Reuters
Health Care Down on Regulatory Fears — Health Care Roundup
Sep 12, 2025 • Morningstar.com
Kenvue Pushes To Defend Pain Killer Tylenol Against Autism Claims Ahead Of Government Report
Sep 12, 2025 • Benzinga.com
Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports
Sep 12, 2025 • MarketScreener
CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report
Sep 12, 2025 • WSJ.com: US Business
Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports
Sep 12, 2025 • MarketScreener
Kenvue CEO met with Robert F. Kennedy Jr. to argue there's no clear link between Tylenol and autism - WSJ
Sep 12, 2025 • MarketScreener
Kenvue lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports
Sep 12, 2025 • thefly.com
Kenvue CEO lobbied RFK Jr. not to cite Tylenol as autism cause, WSJ reports
Sep 12, 2025 • Reuters
Kenvue CEO met RFK Jr., said no clear link between Tylenol and autism, WSJ reports
Sep 12, 2025 • Investing.com
Transforming Packaging: Kenvue's Sustainability Strategy
Sep 10, 2025 • Packaging World
Tylenol maker's stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a 'major overreaction'
Sep 9, 2025 • Fortune
WSJ: Kenvue rejects reported HHS link of autism to painkiller
Sep 8, 2025 • WBAL-TV
Kenvue Falls After Report on Tylenol, Autism Link
Sep 8, 2025 • Yahoo Finance
RFK Jr.'s planned report linking Tylenol to autism crashes shares of parent company Kenvue
Sep 8, 2025 • Fortune
Bank of America sees 'attractive entry point' in Kenvue after Tylenol controversy sparks sell-off
Sep 8, 2025 • CNBC
Kenvue (KVUE): Evaluating Valuation After Tylenol-Autism Headlines Shake Investor Confidence
Sep 8, 2025 • simplywall.st
Goldman Sachs maintains Kenvue stock rating amid potential Tylenol report
Sep 8, 2025 • Investing.com
Kenvue Stock Dips 10% on Concerns Over Tylenol Use During Pregnancy
Sep 8, 2025 • TIKR.com
BofA sees 'particularly attractive entry point' after Kenvue pullback
Sep 8, 2025 • thefly.com
Kenvue Inc put buyer realizes 365% same-day gains
Sep 8, 2025 • thefly.com
BofA Securities reiterates Buy on Kenvue stock amid Tylenol concerns
Sep 7, 2025 • Investing.com
Some suggest Tylenol is linked to autism. Here’s what to know.
Sep 6, 2025 • Star Tribune
Kenvue stock drops 10% on report RFK Jr. will link autism to Tylenol use during pregnancy
Sep 5, 2025 • CNBC
Kenvue: Stock Tumbles on Kennedy’s Pending Report on Tylenol and Autism
Sep 5, 2025 • Morningstar
Kenvue stock hits 52-week low at $19.70
Sep 5, 2025 • Investing.com
Kenvue Stock Falls as Kennedy Plans to Link Autism and Tylenol, Report Says
Sep 5, 2025 • Barron's
Kenvue Stock Hits One-Year Low After Report Says HHS Will Link Tylenol Use In Pregnancy To Autism Risk
Sep 5, 2025 • Stocktwits
Google fined $3.5B, Kenvue sinks, Lululemon: Trending Tickers
Sep 5, 2025 • Yahoo Finance
Kenvue fights back against RFK Jr.’s Tylenol safety concerns as its stock tumbles
Sep 5, 2025 • MarketWatch
Tylenol-maker shares hit after report RFK Jr will suggest autism link
Sep 5, 2025 • BBC
Tylenol Maker Kenvue's Stock Slumps Following Report RFK Jr. Will Link It to Autism
Sep 5, 2025 • Investopedia
HHS to Link Tylenol Use During Pregnancy to Autism, The WSJ Reports; Kenvue Shares Down
Sep 5, 2025 • MarketScreener
Health Care Climbs as Traders Rotate Into Laggard - Health Care Roundup
Sep 5, 2025 • MarketScreener
Kenvue on WSJ report says continue to believe there is no causal link between acetaminophen use during pregnancy and autism - CNBC
Sep 5, 2025 • MarketScreener
What the research says about Tylenol and autism
Sep 5, 2025 • CBS News
Tylenol maker shares sink after report says RFK's HHS will link drug to autism
Sep 5, 2025 • FOXBusiness.com
RFK Jr. To Link Tylenol Use To Autism: Report
Sep 5, 2025 • Benzinga.com
Is Tylenol safe to take during pregnancy?
Sep 5, 2025 • Reuters
Kenvue (KVUE) Slid Due to Operational Challenges
Aug 26, 2025 • Yahoo Finance
Insulet selects new COO and inaugural chief growth officer
Aug 26, 2025 • WBJournal.com
Insulet Elevates Eric Benjamin to Chief Operating Officer
Aug 26, 2025 • BioSpace
Insulet Elevates Eric Benjamin to Chief Operating Officer
Aug 25, 2025 • Business Wire
JNJ Stock Surge Signals Confidence in New Growth Path
Aug 25, 2025 • MarketBeat
Insulet Appoints Eric Benjamin COO
Aug 25, 2025 • citybiz
3 Stable Dividend-Paying Stocks That Are Perfect for Retirees
Aug 21, 2025 • The Motley Fool
From Vanity to Vitality: Brits Are Turning Personal Care Routines into Lifelong Wellness Strategies
Aug 19, 2025 • PharmiWeb
Packaged foods see demand boost
Aug 19, 2025 • IndiaTimes